SA scientists plan AstraZeneca trial to assess effect on severe disease
18 February 2021 - 19:10
The government’s top Covid-19 vaccine advisers met on Thursday to discuss launching a clinical trial of AstraZeneca’s shot, designed to answer key questions about the extent to which the jab protects people from severe disease caused by the new variant dominating transmission in SA.
“The advice under serious discussion is the idea of rolling out a study to 100,000 [volunteers] so we can look at the impact on hospitalisation,” said Helen Rees, executive director of the Wits Reproductive Health and HIV Institute and a member of health minister Zweli Mkhize’s advisory committee on Covid-19 vaccines...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.